Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,661,887
+$1,720,044 QoQ
Shares Held
26,231
+29.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#1,390
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. JNJ ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,661,887 | 26,231 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,941,843 | 20,217 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,978,406 | 19,224 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,481,075 | 18,774 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,867,728 | 18,774 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,167,709 | 19,101 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,886,904 | 19,962 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,245,737 | 20,028 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $2,928,023 | 20,033 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,454,946 | 28,162 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,724,144 | 36,520 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $5,828,632 | 37,423 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,162,144 | 37,229 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,855,745 | 37,779 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,682,492 | 37,829 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,174,027 | 37,794 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,719,463 | 37,854 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,327,819 | 35,704 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,160,059 | 36,009 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,123,757 | 37,918 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,323,215 | 38,383 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,564,632 | 39,943 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,224,064 | 39,548 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,760,018 | 38,689 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,095,024 | 36,230 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,497,103 | 34,295 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||